相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Delineating the anti-metastatic potential of pentoxifylline in combination with liposomal doxorubicin against breast cancer cells
Peeyush N. Goel et al.
BIOMEDICINE & PHARMACOTHERAPY (2014)
Unraveling the cytotoxic potential of Temozolomide loaded into PLGA nanoparticles
Darshana S. Jain et al.
DARU-JOURNAL OF PHARMACEUTICAL SCIENCES (2014)
Studies on stabilization mechanism and stealth effect of poloxamer 188 onto PLGA nanoparticles
Darshana Jain et al.
COLLOIDS AND SURFACES B-BIOINTERFACES (2013)
Unravelling the antimetastatic potential of pentoxifylline, a methylxanthine derivative in human MDA-MB-231 breast cancer cells
Peeyush N. Goel et al.
MOLECULAR AND CELLULAR BIOCHEMISTRY (2011)
In vitro protein adsorption studies on nevirapine nanosuspensions for HIV/AIDS chemotherapy
Ranjita Shegokar et al.
NANOMEDICINE-NANOTECHNOLOGY BIOLOGY AND MEDICINE (2011)
Biodegradable polymeric nanoparticles based drug delivery systems
Avnesh Kumari et al.
COLLOIDS AND SURFACES B-BIOINTERFACES (2010)
Approaches to transport therapeutic drugs across the blood-brain barrier to treat brain diseases
Reinhard Gabathuler
NEUROBIOLOGY OF DISEASE (2010)
Celastrol Synergistically Enhances Temozolomide Cytotoxicity in Melanoma Cells
Ming Chen et al.
MOLECULAR CANCER RESEARCH (2009)
Preparation and in vitro studies of stealth PEGylated PLGA nanoparticles as carriers for arsenic trioxide
Wang Zhiqing et al.
CHINESE JOURNAL OF CHEMICAL ENGINEERING (2007)
Poly(D,L-lactide-co-glycolide) (PLGA) nanoparticles prepared by high pressure homogenization for paclitaxel chemotherapy
Yuancai Dong et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2007)
Efficient gene delivery targeted to the brain using a transferrin-conjugated polyethyleneglycol-modified polyamidoamine dendrimer
Rong-Qin Huang et al.
FASEB JOURNAL (2007)
Preparation and in vitro anticancer activity of wheat germ agglutinin (WGA)-conjugated PLGA nanoparticles loaded with paclitaxel and isopropyl myristate
Y Mo et al.
JOURNAL OF CONTROLLED RELEASE (2005)
Intravenous hydrophobic drug delivery: A porous particle formulation of paclitaxel (AI-850)
JA Straub et al.
PHARMACEUTICAL RESEARCH (2005)
Nanomedicine: current status and future prospects
SM Moghimi et al.
FASEB JOURNAL (2005)
Praziquantel-loaded PLGA nanoparticles: preparation and characterization
RM Mainardes et al.
JOURNAL OF MICROENCAPSULATION (2005)
In vitro and in vivo evaluation of actively targetable nanoparticles for paclitaxel delivery
ZH Xu et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2005)
Nanoparticle and targeted systems for cancer therapy
L Brannon-Peppas et al.
ADVANCED DRUG DELIVERY REVIEWS (2004)
Nonoparticles of biodegradable polymers for new-concept chemotherapy
SS Feng
EXPERT REVIEW OF MEDICAL DEVICES (2004)
Antitumor characteristics of methoxypolyethylene glycol-poly(DL-lactic acid) nanoparticles containing camptothecin
H Miura et al.
JOURNAL OF CONTROLLED RELEASE (2004)
Direct evidence that polysorbate-80-coated poly( butylcyanoacrylate) nanoparticles deliver drugs to the CNS via specific mechanisms requiring prior binding of drug to the nanoparticles
J Kreuter et al.
PHARMACEUTICAL RESEARCH (2003)
Poly(ethylene oxide)-modified poly(β-amino ester) nanoparticles as a pH-sensitive biodegradable system for paclitaxel delivery
A Potineni et al.
JOURNAL OF CONTROLLED RELEASE (2003)
A novel controlled release formulation for the anticancer drug paclitaxel (Taxol®):: PLGA nanoparticles containing vitamin E TPGS
L Mu et al.
JOURNAL OF CONTROLLED RELEASE (2003)
Nanoparticles in cancer therapy and diagnosis
I Brigger et al.
ADVANCED DRUG DELIVERY REVIEWS (2002)
分享论文
